Adverse events12

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 12 of 12

Type	Event	Organ system	Group	Affected	At risk	Events
other	Urinary urgency	Renal and urinary disorders	Dalfampridine	4	13	4
other	Urinary urgency	Renal and urinary disorders	Placebo	5	13	5
other	Insomnia	Nervous system disorders	Dalfampridine	2	13	2
other	Insomnia	Nervous system disorders	Placebo	1	13	1
other	Dizziness	Nervous system disorders	Dalfampridine	0	13	0
other	Dizziness	Nervous system disorders	Placebo	2	13	2
other	Weakness	Nervous system disorders	Dalfampridine	4	13	4
other	Weakness	Nervous system disorders	Placebo	2	13	2
other	Fatigue	Nervous system disorders	Dalfampridine	4	13	4
other	Fatigue	Nervous system disorders	Placebo	4	13	4
other	Muscle stiffness	Nervous system disorders	Dalfampridine	4	13	4
other	Muscle stiffness	Nervous system disorders	Placebo	5	13	5

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02166346/events